申请人:Purdue Pharma L.P.
公开号:US20150322066A1
公开(公告)日:2015-11-12
The disclosure relates to Substituted Benzimidazole-Type Piperidine Compounds of Formula (I):
and pharmaceutically acceptable salts or solvates thereof, e.g., a pharmaceutically acceptable salt or solvate, wherein R
1
, R
2
, R
3
, Q
a
, W, U, A, B, Z, a, and the dashed lines are as defined herein, compositions comprising an effective amount of a Substituted Benzimidazole-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted Benzimidazole-Type Piperidine Compound.